openPR Logo
Press release

Primary Immunodeficiency Diseases Market: Key Insights

02-02-2017 02:43 PM CET | Health & Medicine

Press release from: TMR - Research Reports

With only a handful of companies enjoying the major share of the revenue pie, the global primary immunodeficiency diseases (PIDD) market exhibits a consolidated vendor landscape. As per Transparency Market Research (TMR), CSL Behring LLC and Grifols S.A. emerged dominant in the market with a share of 60.5% in 2014. Baxter International, Inc. and Octapharma AG are other prominent enterprises operating in the global PIDD market.

These companies have been primarily capitalizing on the increasing incidence of immunodeficiency diseases. The rising research and development investments by these companies help them in maintaining competitiveness in the global market. Besides these, favorable government policies and increased funding on pharmaceutical and biopharmaceutical research augur well for the key market players.

Demand for PIDD Therapies to Rise following Newer Government Approvals

The most prominent companies in the PIDD market are focusing on developing novel therapies that provide effective cure for primary immunodeficiency diseases. Such increasing research and development activities and the correspondingly rising approvals of these drugs are primary factors boosting sales from the PIDD market. “Government approvals fuel demand for drugs and treatment modalities for primary immunodeficiency diseases, thus boosting the market’s growth,” said a lead TMR analyst.

Read Full Report: http://www.transparencymarketresearch.com/primary-immunodeficiency-disease-market.html

“The gradually increasing incidence of primary immunodeficiency diseases is also expected to boost demand for PIDD drugs,” he added. With several government and private organizations actively engaging in creating awareness about PIDD by organizing various disease awareness programs, demand for PIDD therapies is likely to surge in both developed and developing regions. As per TMR the aforementioned factors will lead to a higher uptake of PIDD therapies globally.

Absence of Proper Reimbursement Policies Inhibits Widespread Uptake of PIDD Therapies

Despite the rising prevalence of primary immunodeficiency diseases, governments across several nations are yet to draft adequate reimbursement policies. Furthermore, in the absence of adequate provisions for the diagnosis of the ailment in newborns, a large number of cases go undetected in emerging countries. In developed countries however the inadequate reimbursement policies discourage the diagnosis of primary immunodeficiency diseases. These factors will restrict the proliferation of PIDD therapies worldwide.

According to TMR, over 10 million people suffer from primary immunodeficiency diseases around the world. Out of them thousands of cases in adults and children alike go undiagnosed. This acts as a major restraint for the market. Delay in PIDD diagnosis could spur recurrent infections and eventually prove fatal. Early identification of the disease via newborn screening is thus considered indispensable.

Prevalence of Unmet Medical Needs in Emerging Economies to Create Opportunities for Market’s Growth

However, a significant scope for expansion of PIDD diagnostic lies in emerging nations. These nations report a high prevalence of unmet medical needs, which has compelled their government to draft policies favoring the growth of the healthcare sector. Recent policies undertaken by governments across developing countries and the favorable health trends in Asia Pacific have created opportunities for the increasing adoption of PIDD therapies.

Regionally, North America and Europe emerged dominant in the global PIDD market with a share of 79.4% in 2014. Among these nations North America held the largest share of over 56.2% in the market. The rising prevalence of PIDD boosts the demand for PIDD therapies and drugs in North America. The presence of leading companies in Europe, has proven beneficial for the region’s PIDD market.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3137

By treatment, the demand for immunoglobulin replacement is expected to surge exponentially. TMR also forecasts the demand for stem cell and gene therapy for PIDD treatment to increase in the near future.

As per Transparency Market Research, the global primary immunodeficiency market stood at US$4.3 bn in 2014. Rising at a CAGR of 6.1% between 2015 and 2023, the market is expected to reach US$7.5 bn by the end of 2023.

This review is based on information published by TMR in a report, titled “Primary Immunodeficiency Diseases Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023”

Key Takeaways:

North America and Europe emerged as leading regional markets holding a share of 79.4% in 2014
Global PIDD market exhibits a consolidated vendor landscape with the top two players accounting for over 60.5% share in 2014
Inadequate reimbursement threatens the market’s expansion worldwide
Rising demand for newborn screening in developing markets to create growth opportunities
The global primary immunodeficiency diseases market is segmented as follows:

Global Primary Immunodeficiency Diseases Market, by Disease

Antibody Deficiency
Agammaglobulinaemia ((X-Linked and Autosomal Recessive)
Common Variable Immune Deficiency
Selective IgA Deficiency
IgG Subclass Deficiency
Others
Cellular Immunodeficiency
Ataxia Telangiectasia
Hyper IgM Syndromes
Wiskott-Aldrich Syndrome
DiGeorge Syndrome
Others
Innate Immune Disorders
Complement Deficiencies
Hyper IgE Syndrome
Others
Global Primary Immunodeficiency Diseases Market, by Test

Blood Test
Prenatal Testing
Global Primary Immunodeficiency Diseases Market, by Treatment

Immunoglobulin Replacement Therapy
Antibiotic Therapy
Stem cell and Gene Therapy
Others
Global Primary Immunodeficiency Diseases Market, by Geography

North America
Latin America
Europe
Asia Pacific
Rest of the World

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Primary Immunodeficiency Diseases Market: Key Insights here

News-ID: 427017 • Views: 209

More Releases from TMR - Research Reports

Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to

All 5 Releases


More Releases for PIDD

Primary Immunodeficiency Diseases Market is expected to reach US$7.5 bn by the e …
As per Transparency Market Research, the global primary immunodeficiency market stood at US$4.3 bn in 2014. Rising at a CAGR of 6.1% between 2015 and 2023, the market is expected to reach US$7.5 bn by the end of 2023. Prevalence of Unmet Medical Needs in Emerging Economies to Create Opportunities for Market’s Growth However, a significant scope for expansion of PIDD diagnostic lies in emerging nations. These nations report a
Primary Immunodeficiency Diseases Market is rising at a CAGR of 6.1% till 2023
As per Transparency Market Research, the global primary immunodeficiency market stood at US$4.3 bn in 2014. Rising at a CAGR of 6.1% between 2015 and 2023, the market is expected to reach US$7.5 bn by the end of 2023. Prevalence of Unmet Medical Needs in Emerging Economies to Create Opportunities for Market’s Growth However, a significant scope for expansion of PIDD diagnostic lies in emerging nations. These nations report a
Primary Immunodeficiency Diseases Market to Rise to US$7.5 bn by 2023
The global primary immunodeficiency diseases market was recorded at US$4.4 bn in 2014. It is expected to exhibit a CAGR of 6.10% within a forecast period from 2015 to 2023. The market could hold a potential value of US$7.6 bn by the end of 2023, according to a research report released by Transparency Market Research. The report, titled “Primary Immunodeficiency Diseases Market - Global Industry Analysis, Size, Share, Growth, Trends
Primary Immunodeficiency Diseases Market is Expected to Rise at a Remarkable CAG …
With only a handful of companies enjoying the major share of the revenue pie, the global primary immunodeficiency diseases (PIDD) market exhibits a consolidated vendor landscape. As per Transparency Market Research (TMR), CSL Behring LLC and Grifols S.A. emerged dominant in the market with a share of 60.5% in 2014. Baxter International, Inc. and Octapharma AG are other prominent enterprises operating in the global PIDD market. These companies have been
Worldwide Primary Immunodeficiency Diseases Market Opportunities: New Born Scree …
Primary immunodeficiency diseases (PIDD) comprise a group of 200+ immune disorders wherein a part of the body’s immune system is either absent or does not function properly. The conditions, which result because of a single-gene defect, are passed down from either one or both parents. In the most common form, PIDDs occur due to problems in DNA that result in a lack of white blood cells, which the immune system
Comparative Analysis: Global Primary Immunodeficiency Diseases Market, by Geogra …
As per Transparency Market Research, the global primary immunodeficiency market stood at US$4.3 bn in 2014. Rising at a CAGR of 6.1% between 2015 and 2023, the market is expected to reach US$7.5 bn by the end of 2023. Primary Immunodeficiency Diseases Market: Key Insights In response to the rising incidence of antibody diseases, Transparency Market Research (TMR) forecasts the global primary immunodeficiency market to surge at 6.1% CAGR between 2015 and